## **Core Concept**
Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from the parafollicular cells, also known as C cells, which produce calcitonin. It accounts for about 5-10% of all thyroid cancers. The treatment of MTC often involves a combination of surgical and medical management.

## **Why the Correct Answer is Right**
The correct answer, **Total thyroidectomy**, is the treatment of choice for medullary carcinoma of the thyroid because it aims to remove the entire thyroid gland, which can harbor multiple foci of cancer, especially in familial cases. This approach helps in reducing the risk of local recurrence and facilitates the use of postoperative calcitonin levels as a tumor marker for detecting recurrence. Additionally, total thyroidectomy is often recommended even for apparently sporadic cases due to the high likelihood of multicentricity.

## **Why Each Wrong Option is Incorrect**
- **Option A: Radioiodine therapy** is not typically used for MTC because these cells do not take up iodine due to their origin from parafollicular C cells, which do not produce thyroglobulin or take up iodine.
- **Option B: Hemithyroidectomy** might be considered for some benign thyroid conditions or for diagnostic purposes in certain cases of thyroid cancer, but it is not sufficient for the treatment of MTC due to the high risk of multicentricity and bilaterality, especially in familial forms.
- **Option D: Chemotherapy** can be considered in advanced or metastatic disease but is not the primary treatment for localized MTC.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **screening for RET proto-oncogene mutations** is crucial in all patients with medullary thyroid carcinoma, as these mutations are associated with familial MTC and multiple endocrine neoplasia type 2 (MEN2) syndromes. Early identification can lead to prophylactic thyroidectomy in family members at risk.

## **Correct Answer:** . Total thyroidectomy